Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Bites and Stings × Hydroxyurea × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Leukemia 8 Brain Neoplasms 8 Squamous Cell Carcinoma of Head and Neck 7 Leukemia, Myeloid, Chronic-Phase 7 Leukemia, Myeloid, Acute 7 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 7 Glioblastoma 7 Polycythemia Vera 6 Meningioma 6 Head and Neck Neoplasms 6 Gliosarcoma 5 Myelodysplastic Syndromes 4 Glioma 4 Central Nervous System Neoplasms 4 Neoplasms 3 Myeloproliferative Disorders 3 Leukemia, Myelomonocytic, Chronic 3 Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 3 Esophageal Neoplasms 3 Stomach Neoplasms 2 Salivary Gland Neoplasms 2 Myelodysplastic-Myeloproliferative Diseases 2 Laryngeal Neoplasms 2 Hypopharyngeal Neoplasms 2 Congenital Abnormalities 2 Treatment-Refractory Solid Tumors 1 Tongue Neoplasms 1 Thyroid Carcinoma, Anaplastic 1 Thrombosis 1 Thrombocytosis 1

Interventions

pembrolizumab 3 blinatumomab 2 Stents 2 AMG 757 2 soybean oil, phospholipid emulsion 1 enzalutamide 1 durvalumab 1 dostarlimab 1 cemiplimab 1 camrelizumab 1 atezolizumab 1 abiraterone 1 Surgical Procedures, Operative 1 Surgical Instruments 1 Radiotherapy, Conformal 1 Radiotherapy 1 Passive Cutaneous Anaphylaxis 1 Palliative Care 1 Nephrotomy 1 Nephrostomy, Percutaneous 1 Neoadjuvant Therapy 1 N,N-dicyclohexyl-isoborneol-10-sulfonamide 1 Morphine 1 Lidocaine 1 Levobupivacaine 1 Immunotherapy 1 Immune Checkpoint Inhibitors 1 Hydroxyurea 1 Etoposide 1 Etanercept 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06063317 2026-03-06

OASIS

Imugene Limited

Phase 1 Terminated

Bites and Stings

Data powered by HemOnc (CC BY 4.0) Colophon ⚡